Bundled Payments Save $33M in Cancer Care: How Can Other Specialties Do the Same?
study of bundled payments in five medical oncology groups. Through the alternative to fee-for-service payment model, the total cost of care for patients with three different types of cancer was reduced by $33 million.
Here are four things to know about the study and movements towards bundled payments across the healthcare field.
1. UnitedHealth Group and five medical oncology groups partnered to conduct the study, published in the Journal of Oncology Practice. The study included medical costs for 810 patients with lung, breast and colon cancer between 2009 and 2012. Physicians were received a bundled episode of care payment, rather than being reimbursed for individual services.
2. The medical costs for the 810 patients included in the study totaled $65 million. On the other hand, similar patients receiving care under standard fee-for-service demonstrated a total cost of $98 million. Unexpectedly, the costs of chemotherapy increased in study group in comparison to the standard payment group.
3. Bundled payments are not a new concept, but the alternative model is fairly new in practice. A recent Health Care Incentives Improvement Institute study examined six payers working with bundled payments. One began a bundled program in 2006, while the remaining five began within the past three years. Hip and knee replacement were the two most commonly reported procedures for a bundled payment model.
4. Bundled payments hold the promise of cost savings, as indicated in Journal of Oncology Practice study, have yet to become widespread in the ambulatory surgery center industry. But, progress has been made in areas such as colonoscopy. The American Gastroenterological Association released a potential bundled model for colonoscopy. Bedford (N.H.) Ambulatory Surgical Center and Harvard-Pilgrim Healthcare launched a pilot program for bundled payments in colonoscopy.
More Articles on Coding and Billing:
2 Tips for EHR Implementation at ASCs
Another ICD-10 Delay Would Cost Additional $1B to $6.6B
Brian Holland Named MediGain VP of Operations
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's ASC Review